CALLIE LAND: Open Payments
NPI 1245787365 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,614 in 69 payments from 13 companies in 2025. Trend: 2023 $1,568 · 2024 $1,545 · 2025 $1,614
Food & beverage: $1,503Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $557 |
| ABBVIE INC. | 10 | $283 |
| Axsome Therapeutics, Inc. | 14 | $205 |
| Teva Pharmaceuticals USA, Inc. | 6 | $183 |
| Alkermes, Inc. | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
Products named: INGREZZA, VRAYLAR, Auvelity, ARISTADA, AUSTEDO XR, TRINTELLIX, Qelbree, REXULTI.
Industry payments across TX — which companies pay providers there.
